학술논문
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)
Document Type
Article
Author
Hasan, H.; Deek, M.P.; Phillips, R.; Hobbs, R.F.; Malek, R.; Radwan, N.; Kiess, A.P.; Dipasquale, S.; Huang, J.; Caldwell, T.; Leitzel, J.; Wendler, D.; Dudley, S.; Deville, C.; Greco, S.C.; Song, D.Y.; Deweese, T.L.; Tran, P.T.; Wang, H.; Thompson, E.; Powell, J.; Gorin, M.A.; Denmeade, S.; Markowski, M.; Antonarakis, E.S.; Carducci, M.A.; Eisenberger, M.A.; Pienta, K.J.; Paller, C.J.; Rowe, S.P.; Pomper, M.G.
Source
In: BMC Cancer . (BMC Cancer, 1 June 2020, 20(1))
Subject
Language
English
ISSN
14712407